Page last updated: 2024-11-03

rizatriptan and Brain Neoplasms

rizatriptan has been researched along with Brain Neoplasms in 1 studies

rizatriptan: structure given in first source; RN given refers to benzoate

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Satow, T1
Saiki, M1
Kishi, Y1
Fukuda, M1
Nakaoku, T1
Nakatani, K1

Other Studies

1 other study available for rizatriptan and Brain Neoplasms

ArticleYear
Rizatriptan is effective for headache in a patient with meningeal carcinomatosis.
    Journal of pain and symptom management, 2011, Volume: 41, Issue:5

    Topics: Brain Neoplasms; Female; Headache; Humans; Meningeal Carcinomatosis; Middle Aged; Serotonin Receptor

2011